Early Intervention in Severe Fetal Megacystis Can Increase Survival Rate and Kidney Function

A groundbreaking study conducted by University Hospitals Cologne and Bonn has demonstrated that early intervention for congenital lower urinary tract obstruction (cLUTO) – specifically, vesicoamniotic shunt implantation during the first trimester – significantly improves survival rates and preserves kidney function in affected fetuses. This approach aims to potentially spare infants from lifelong dialysis.

Understanding Congenital Lower Urinary Tract Obstruction

Congenital lower urinary tract obstruction (cLUTO) is a critical prenatal condition characterized by a blockage in the fetus’s urine flow. This obstruction leads to urine accumulation, increasing pressure that overstretches the urinary tract and disrupts the natural development of the kidneys. The increased pressure can cause irreversible damage to developing renal tissue during organogenesis. Reduced amniotic fluid, a consequence of diminished urine output, can also lead to lethal pulmonary hypoplasia, a major cause of postnatal mortality in cLUTO-affected infants.

The Shift to Early Intervention

Historically, interventions for cLUTO were typically performed during the second trimester. However, recent research, spearheaded by Professor Christoph Berg, Head of Foetal Surgery at University Hospital Cologne, suggests a more effective strategy. “The change in strategy is based on developmental biology considerations,” explains Professor Berg. “In early pregnancy, the kidney is in a particularly sensitive phase of development.”

Experimental studies indicate that sustained pressure from urinary retention can permanently damage the precursor cells of the kidney. By relieving this pressure very early in the pregnancy, researchers aim to protect this critical phase of kidney development.

Study Findings: IUS1st Trial

The prospective study, titled ‘Intrauterine shunting for first-trimester fetal megacystis (IUS1st)’ and published in “The Lancet Child & Adolescent Health” on March 12, 2026, examined 40 pregnancies with severe fetal megacystis. The results showed:

• 75 percent of children were born alive.
• 68 percent survived their first year of life.
• Of the 29 survivors who received active treatment, 90 percent did not require dialysis during their first year.
• Most survivors exhibited normal or only slightly impaired kidney function.

Interdisciplinary Collaboration

The success of this approach is attributed to the close collaboration between prenatal medicine, pediatric nephrology, pediatric urology, and neonatology at the University Hospitals of Cologne and Bonn. This interdisciplinary collaboration is a core principle of the Center for Family Health (CEFAM) at the University Hospital of Cologne, which aims to provide comprehensive support to patients from prenatal findings through long-term care, as noted by Univ.-Prof. Dr. Jörg Dötsch, Director of the Clinic for Pediatric and Adolescent Medicine at the University Hospital of Cologne.

Implications for the Future

These findings underscore the importance of early diagnosis and innovative treatment strategies for congenital kidney diseases, even before birth. Professor Berg’s operate identifies a developmental biology rationale as the foundation for the success of the early shunting program, with implications extending beyond cLUTO .